IOBT – io biotech, inc. (US:NASDAQ)
Stock Stats
News
IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate [Yahoo! Finance]
IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate
IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer
IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank [Yahoo! Finance]
IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank
Form SCHEDULE 13G/A IO Biotech, Inc. Filed by: Samsara BioCapital, L.P.
Form SCHEDULE 13G/A IO Biotech, Inc. Filed by: HBM Healthcare Investments (Cayman) Ltd.
Form 8-K IO Biotech, Inc. For: Dec 26
Form 4 IO Biotech, Inc. For: Dec 23 Filed by: Ahmad Qasim Iftikhar
Form 4 IO Biotech, Inc. For: Dec 23 Filed by: Zocca Mai-Britt
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.